MedTrace Logo

VIdeo Telehealth in ALzheimer's: NeuroPsychology (VITAL-NP)

NCT05379023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2025-12-31

Study results available
· View outcomes & findings →

Summary

The overarching goal of this study is to a) assess the feasibility and preliminary validity of home-based delivery of TeleNP to patients with suspected Alzheimer's Disease (AD), referred for cognitive assessments in a Neurology Clinic; and b) elucidate whether TeleNP is equivalent to face-to-face evaluation (FF) for diagnostic adjudication of atypical versus typical AD.

Conditions

  • Suspected Typical Alzheimer's Disease (AD)
  • Suspected Atypical Alzheimer's Disease (AD)

Interventions

BEHAVIORAL

TeleNP evaluation

The intervention is the assessment modality. The intervention condition is TeleNP evaluation.

BEHAVIORAL

Face-to-face evaluation (FF)

The intervention is the assessment modality. The control condition is face-to-face evaluation (FF).

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Brianne Bettcher, PhD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-27
Primary Completion
2024-05-16
Completion
2024-05-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05379023 on ClinicalTrials.gov